Nov 26 2013 |
Health Care Reform Update - Week of November 26, 2013 |
Mintz |
Nov 26 2013 |
Genetic Information Nondiscrimination Act (GINA) Much Ado About Nothing? |
Barnes & Thornburg LLP |
Nov 26 2013 |
Annual Fee On Insurers To Impact Small Businesses |
Giordano, Halleran & Ciesla, P.C. |
Nov 26 2013 |
National Practitioner Data Bank Issues Draft Revised Guidebook |
Katten |
Nov 26 2013 |
Food and Drug Administration (FDA) Extends Comment Periods for Food-Related Rules and Guidance |
Barnes & Thornburg LLP |
Nov 25 2013 |
Affordable Care Act Checkup: 2014 Payroll |
Mintz |
Nov 25 2013 |
Federal Trade Commission (FTC) Focuses Enforcement Efforts on Health Care, Technology and Energy Sectors |
McDermott Will & Emery |
Nov 25 2013 |
Office of Inspector General (OIG) Defines its Priorities in 2014-2018 Strategic Plan |
Mintz |
Nov 25 2013 |
Webcast: Part 1 on Informed Consent and Part 2 on Tuomey, Bradford, Intermountain |
von Briesen & Roper, s.c. |
Nov 24 2013 |
HHS Releases Notices for Transition to ACA Compliant Insurance Policies |
von Briesen & Roper, s.c. |
Nov 23 2013 |
Wisconsin Insurance Commissioner Will Allow Extensions of Non-ACA Compliant Plans |
von Briesen & Roper, s.c. |
Nov 23 2013 |
Offering Safety and Health Assistance to Midwest Tornado Damaged Communities |
U.S. Department of Labor |
Nov 22 2013 |
Food and Drug Administration (FDA) Final Guidance on Mobile Medical Applications |
Faegre Drinker |
Nov 22 2013 |
Treasury Department/IRS Issue Guidance Instructing Employers on How to Make Claims for FICA (Federal Insurance Contributions Act) Refunds or Credits Post-Windsor |
Mintz |
Nov 22 2013 |
Occupational Safety and Health Administration (OSHA) Proposed Rule for Crystalline Silica |
Greenberg Traurig, LLP |
Nov 22 2013 |
Legalization of Same-Sex Marriage in Illinois Means Federal Benefits for Same-Sex Spouses |
Barnes & Thornburg LLP |
Nov 22 2013 |
Use It or Lose It: New IRS Guidance Permits Carryover for Health FSAs (Flexible Spending Account) |
Faegre Drinker |
Nov 21 2013 |
Impact of Healthcare Mobile Apps on Treatment |
Faegre Drinker |
Nov 21 2013 |
IRS Modifies "Use It Or Lose It" Rule for Health Flexible Spending Accounts |
von Briesen & Roper, s.c. |
Nov 21 2013 |
Top Ten Ways Hospitals and Health Systems Can Survive in the Current Federal Health Care Policy Environment - Webinar Recap |
Faegre Drinker |
Nov 20 2013 |
Useful Online Guide To Keeping Tabs On The Affordable Care Act (ACA) |
Barnes & Thornburg LLP |
Nov 20 2013 |
The ObamaCare Rollout Debacle Impact on Providers in New Jersey |
Giordano, Halleran & Ciesla, P.C. |
Nov 20 2013 |
November 2013 New Jersey Regulatory Developments |
Giordano, Halleran & Ciesla, P.C. |
Nov 20 2013 |
U.S. Department of Health and Human Services (HHS) Requests Comments on How to Measure Quality of Exchange Plans |
von Briesen & Roper, s.c. |
Nov 19 2013 |
Dewonkify – Medicare Part D |
Faegre Drinker |
Nov 19 2013 |
President Obama Announces Transition Relief for Certain Group Health Plans |
von Briesen & Roper, s.c. |
Nov 19 2013 |
Family Medical Leave Act (FMLA): Telecommuters, Offsite Employees and the Modern Workplace |
Varnum LLP |
Nov 19 2013 |
Final Regulations on the Mental Health Parity and Addiction Equity Act of 2008 and New Affordable Care Act FAQs |
McDermott Will & Emery |
Nov 19 2013 |
Does Ping Still Pack a Punch? Kentucky Court Says Broader Power of Attorney Can Sign Arbitration Agreement |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
Nov 19 2013 |
Health Care Law Update - November 19, 2013 |
Mintz |
Nov 19 2013 |
Federal Trade Commission (FTC) Broadens Notification Requirements for Transfers of Pharmaceutical Patent Rights |
Bracewell LLP |
Nov 18 2013 |
No Avoiding BPCIA (Biologics Price Competition and Innovation Act) For Biosimilars: No Patent Declaratory Judgment Action Before Biosimilars Application Is Filed |
Sheppard, Mullin, Richter & Hampton LLP |
Nov 18 2013 |
Court Rules Florida Hospital Violated Stark Law in Oncologist Payment Case |
Faegre Drinker |
Nov 18 2013 |
Pay-for-delay to Stay FTC’s (Federal Trade Commission) Top Priority |
McDermott Will & Emery |
Nov 18 2013 |
Heartburn for Drug Manufacturers: "Reverse Payment" That Did Not Include a Monetary Payment Held Actionable Under the Antitrust Laws |
Greenberg Traurig, LLP |